» Articles » PMID: 33669995

A Fundamental Role for Oxidants and Intracellular Calcium Signals in Alzheimer's Pathogenesis-And How a Comprehensive Antioxidant Strategy May Aid Prevention of This Disorder

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Mar 6
PMID 33669995
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Oxidative stress and increased cytoplasmic calcium are key mediators of the detrimental effects on neuronal function and survival in Alzheimer's disease (AD). Pathways whereby these perturbations arise, and then prevent dendritic spine formation, promote tau hyperphosphorylation, further amplify amyloid β generation, and induce neuronal apoptosis, are described. A comprehensive program of nutraceutical supplementation, comprised of the NADPH oxidase inhibitor phycocyanobilin, phase two inducers, the mitochondrial antioxidant astaxanthin, and the glutathione precursor N-acetylcysteine, may have important potential for antagonizing the toxic effects of amyloid β on neurons and thereby aiding prevention of AD. Moreover, nutraceutical antioxidant strategies may oppose the adverse impact of amyloid β oligomers on astrocyte clearance of glutamate, and on the ability of brain capillaries to export amyloid β monomers/oligomers from the brain. Antioxidants, docosahexaenoic acid (DHA), and vitamin D, have potential for suppressing microglial production of interleukin-1β, which potentiates the neurotoxicity of amyloid β. Epidemiology suggests that a health-promoting lifestyle, incorporating a prudent diet, regular vigorous exercise, and other feasible measures, can cut the high risk for AD among the elderly by up to 60%. Conceivably, complementing such lifestyle measures with long-term adherence to the sort of nutraceutical regimen outlined here may drive down risk for AD even further.

Citing Articles

Targeting Mitochondrial Dysfunction in Cerebral Ischemia: Advances in Pharmacological Interventions.

Belenichev I, Popazova O, Bukhtiyarova N, Ryzhenko V, Pavlov S, Suprun E Antioxidants (Basel). 2025; 14(1).

PMID: 39857442 PMC: 11760872. DOI: 10.3390/antiox14010108.


AI reveals insights into link between CD33 and cognitive impairment in Alzheimer's Disease.

Raschka T, Sood M, Schultz B, Altay A, Ebeling C, Frohlich H PLoS Comput Biol. 2023; 19(2):e1009894.

PMID: 36780558 PMC: 9956604. DOI: 10.1371/journal.pcbi.1009894.


Deregulation of Mitochondrial Calcium Handling Due to Presenilin Loss Disrupts Redox Homeostasis and Promotes Neuronal Dysfunction.

Ryan K, Laboy J, Norman K Antioxidants (Basel). 2022; 11(9).

PMID: 36139715 PMC: 9495597. DOI: 10.3390/antiox11091642.


Exploring the Therapeutic Potential of Phytochemicals in Alzheimer's Disease: Focus on Polyphenols and Monoterpenes.

Piccialli I, Tedeschi V, Caputo L, DErrico S, Ciccone R, De Feo V Front Pharmacol. 2022; 13:876614.

PMID: 35600880 PMC: 9114803. DOI: 10.3389/fphar.2022.876614.


Nutrigenomic Studies on the Ameliorative Effect of Enzyme-Digested Phycocyanin in Alzheimer's Disease Model Mice.

Imai Y, Koseki Y, Hirano M, Nakamura S Nutrients. 2021; 13(12).

PMID: 34959983 PMC: 8707209. DOI: 10.3390/nu13124431.


References
1.
Li D, Ferguson A, Cervinski M, Lynch K, Kyle P . AACC Guidance Document on Biotin Interference in Laboratory Tests. J Appl Lab Med. 2020; 5(3):575-587. DOI: 10.1093/jalm/jfz010. View

2.
Zagorska A, Dulak J . HIF-1: the knowns and unknowns of hypoxia sensing. Acta Biochim Pol. 2004; 51(3):563-85. View

3.
Haul S, Godecke A, Schrader J, Haas H, Luhmann H . Impairment of neocortical long-term potentiation in mice deficient of endothelial nitric oxide synthase. J Neurophysiol. 1999; 81(2):494-7. DOI: 10.1152/jn.1999.81.2.494. View

4.
Selley M . Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease. Neurobiol Aging. 2003; 24(7):903-7. DOI: 10.1016/s0197-4580(03)00007-1. View

5.
He X, Yan N, Zhang H, Qi Y, Zhu L, Liu M . Hydrogen sulfide improves spatial memory impairment and decreases production of Aβ in APP/PS1 transgenic mice. Neurochem Int. 2014; 67:1-8. DOI: 10.1016/j.neuint.2014.01.004. View